EMA of Treatment Mediators and Proximal Predictors of Smoking During a Quit Attempt Danielle E. McCarthy, Ph.D. March 13, 2012.

Slides:



Advertisements
Similar presentations
2008 Johns Hopkins Bloomberg School of Public Health Setting Up a Smoking Cessation Clinic Sophia Chan PhD, MPH, RN, RSCN Department of Nursing Studies.
Advertisements

Results Introduction Tobacco use is the leading preventable cause of death in Wisconsin and the United States. Given the risk of smoking initiation during.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Individual Differences in Impulsive-like Behavior & Sensitivity to Money as a Function of Sensation Seeking Status LaBedz, S., Babalonis, S., & Kelly,
Smoking Cessation & Pregnancy Susan A. Albrecht, PhD, RN Donna D. Caruthers, PhD(c), RN University of Pittsburgh School of Nursing Supported by: National.
Georgia Tech Be Well, Benefits Education & Wellness Series August 19, 2014 Quit Smoking: Tools to Kick the Habit.
Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore PRABHAKARAN.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Vaping profiles and preferences: an online survey of electronic cigarette users Dawkins, L., Turner, J. Roberts, A. & Soar, K. Drugs & Addictive Behaviours.
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
TREATING SPECIAL POPULATIONS. OVERVIEW Tobacco Treatment Smoking Outcomes Co-occurring Disorders Integration Tobacco Prevention.
Does Web-Based ACT Help Smokers with Depressive Symptoms to Quit? Helen A. Jones University of Washington Fred Hutchinson Cancer Research Center, Seattle.
PERSONALITY DISORDER SYMPTOMS AND DRINKING MOTIVES AS PREDICTORS OF ALCOHOL CONSUMPTION AND CONSEQUENCES. Sarah L. Tragesser, Aesoon Park, Kenneth J. Sher,
The Ohio Partners for Smoke-Free Families 5A’s
Quitting Smoking How to stop smoking … for good!.
Reducing Anxiety Christine Velardi. The Power of Positive Recollections: Reducing Test Anxiety and Enhancing College Student Efficacy and Performance.
Journal Club Sidharth Bagga MD. Cytisus laborium L. (Golden rain acacia)
Relapse Back to Smoking: The Core Role of the Tobacco Withdrawal Syndrome WITH THOMAS PIASECKI MICHAEL FIORE.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Prevention strategies and treatments HANEWINKEL AND WIBORG DAVIS ET. AL Claire Evenson, Niveda Ganesh, Nadia McCloskey, and Heather Purchas.
 Talks will be available at methodology.psu.edu.
Can undergoing an internet based ACT intervention change the impact of predictors thought to lead to Substance Use? Leonidou. G., Savvides. S., N. & Karekla.
1 Class 10 Ecological Momentary Assessment and Factor Analysis December 8, 2005 Anita L. Stewart Institute for Health & Aging University of California,
Conceptual Considerations for Analysis of EMA Data
Smoke-Free Homes & Smoking Cessation TUS-CPS overlap sample Karen Messer, Ph D Moores UCSD Cancer Center.
Are outcome expectancies the possible targets of smoking prevention? The roles of smoking outcome expectancies in adolescent smoking Urbán Róbert PhD Eötvös.
 2008 Johns Hopkins Bloomberg School of Public Health Evaluating Mass Media Anti-Smoking Campaigns Marc Boulay, PhD Center for Communication Programs.
Treating Chronic Pain in Adolescents Amanda Bye, PsyD, Behavioral Medicine Specialist Collaborative Family Healthcare Association 15 th Annual Conference.
Using EMA Data to Examine Negative Affect and Craving During a Quit Attempt Megan E. Piper, Ph.D. Assistant Professor Center for Tobacco Research & Intervention.
Copyright restrictions may apply Predictive Values of Psychiatric Symptoms for Internet Addiction in Adolescents: A 2-Year Prospective Study Ko C-H, Yen.
OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: Racial/ethnic differences Lirio S. Covey, 1 Mei-Chen Hu,
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Observed Ward Behavior Strongly Associated with Real World Living Skills: An Analysis of Concurrent Validity between NOSIE and ILSI Charlie A. Davidson,
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
1 Impact of Depression History on Tobacco Withdrawal and Relapse Among Female Smokers David W. Wetter, Ph.D. Department of Behavioral Science Funded by.
Melissa Natzke Doctor of Pharmacy Candidate
“Comparing Two web-based Smoking Cessation Programs: Randomized- Controlled Trial” By: McKay et. Al.
Addressing Nicotine Dependence in Drug Treatment Kimber Paschall Richter, PhD, MPH Robert M. McCool, MS University of Kansas School of Medicine, Kansas.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
A health magazine recently reported a study in which researchers claimed that iron supplements increased memory and problem-solving abilities in a random.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Social Anxiety and College Drinking: An Examination of Coping and Conformity Drinking Motives Lindsay S. Ham, Ph.D. and Tracey A. Garcia, B.A. Florida.
REFERENCES Bargh, J. A., Gollwitzer, P. M., Lee-Chai, A., Barndollar, K., & Troetschel, R. (2001). The automated will: Nonconscious activation and pursuit.
Short-term efficacy of nicotine replacement therapy (NRT) for smoking cessation among adolescents and the role of compliance Charlotte Scherphof* Regina.
Introduction ► Despite efforts to reduce heavy drinking among college students, college-student alcohol use and its negative consequences remains a concern.
Dr. Adair, Is Marijuana really addictive? J. Randle Adair, D.O., Ph.D. Diplomate, American Board of Internal Medicine Certified, American Society of Addiction.
Environmental and Social Influences on Tobacco Use Among 18 to 24 Year-Olds in Idaho Dr. John Hetherington Clearwater Research, Inc. Influences on Young.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Method Introduction Results Discussion Mean Negative Cigarette Systoli Previous research has reported that across the nation 29% of college students engage.
Smoking in England Robert West Jamie Brown University College London 1.
1 Behaviour change in theory and in real life Robert West University College London Stockholm, April 2008.
1 Recent studies of clinical significance University College London June 2011 Robert West.
Acute exercise effects on craving and withdrawal symptoms among women attempting to quit smoking using nicotine replacement therapy Dr. Therese Harper.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2013.
UTILIZING TELEPHONE INTERVIEWERS AS COUNSELORS: LESSONS LEARNED FROM A SMOKING REDUCTION STUDY Bridget Gaglio, MPH 1, Tammy Smith, BS 2, Erica Ferro, MA.
Converging evidence indicates that increasing activity in the left dorsolateral prefrontal cortex (DLPFC) with high frequency repetitive transcranial magnetic.
Clare Meernik, MPH 1 ; Anna McCullough, MSW, MSPH, CTTS 1 ; Leah Ranney, PhD 1 ; Barbara Walsh 2 ; Adam O. Goldstein, MD, MPH 1 Predictors of Quit for.
1 How best to motivate and help smokers to stop University College London November 2010 Robert West.
Tobacco dependence: A race by smoker type interaction
How stages of change can predict screening and brief intervention outcome for alcohol problems in young adult emergency department patients.
EMA Outcome Measures in a Clinical Trial
ABCs of Behavioral Support
Mindfulness-based Smoking Cessation among
Charles C. Benight, Ph. D. , Lesley Johnson, B. A
Helping younger smokers quit:
Presentation transcript:

EMA of Treatment Mediators and Proximal Predictors of Smoking During a Quit Attempt Danielle E. McCarthy, Ph.D. March 13, 2012

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Learning Objectives Learn about discoveries regarding treatment mediators and proximal predictors of smoking made using EMA Learn about ways to use existing software to develop tailored self-report and cognitive and behavioral EMA Learn about the validity of real-time, field measures of impulsivity 2

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Mediators of treatment effects Bupropion SR (McCarthy et al., 2008, Addiction) –Positive affect on quit day –Craving decline 1 st week –Motivation to quit 1 st week –Self-efficacy 1 st week Brief counseling (McCarthy et al., 2010, Addiction) –Self-efficacy 1 st month post-quit –Decline in perceived difficulty quitting over 1 st month post-quit 3

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Predictors of Point-Prevalence Abstinence 3 months post-quit (N=70; McCarthy et al., 2006, J Abnormal) –Pre-quit negative affect increases –Craving increases at outset of attempt 2 months post-quit (N=372; McCarthy et al., 2010, Addiction) –Social support received –Access to cigarettes –Increasing attempts to prevent urges –Motivation to quit –Withdrawal distress –Post-lapse demoralization Stressful events 4

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior 5 Stress Coping Smoking Pre-Quit Coping Experience Relations among coping, affect, and smoking over 48 hours (Minami et al., 2011, Addiction) + Negative Affect Positive Affect Urge Coping Gender

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior 6 Positive Affect Smoking Trigger exposure Relations among affect, cognition, and smoking over 24 hours (Minami et al., in preparation) Confidence Motivation Negative Affect Time b/n reports

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Current Study Questions Can impulsivity be measured in real time in subjects’ natural environments? Can real-time assessment tell us more about smoking cessation success than baseline assessment? What variables influence impulsivity within subjects?

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior How is impulsivity related to smoking? Smokers more impulsive than nonsmokers or ex-smokers (see Mitchell, 2004 for review) Impulsivity may be a marker for risk of cessation failure or relapse –Among recent quitters, delay discounting and risk aversion predictive of relapse latency (Goto et al., 2009) Impulsivity may be dynamic –Discounting greater in drive states (Lowenstein, 2005; Giordano et al., 2002)

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Study Design Prospective longitudinal study Smokers attempting to quit Followed 1 week pre- and 3 weeks post-quit –4 EMA reports per day for 28 days All smokers received treatment –4 15-minute individual counseling sessions –12-week supply of 2- or 4-mg nicotine lozenges

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Participants Inclusion criteria: –At least 18 years of age –At least 10 cigarettes per day for at least 6 months –CO at least 8 ppm –Able to read and write English –Willing to complete 5 office visits and 4 EMA reports daily for 4 weeks –Motivated to quit smoking (at least 6 on a 10- point scale)

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Participants Exclusion criteria –Use of other tobacco, marijuana, or other drugs in the past month –Concurrent use of other stop smoking treatments –Serious psychopathology (bipolar disorder, schizophrenia, other psychotic disorder) –Contraindications to lozenge use –Unwillingness to prevent pregnancy

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Participants 99 adult smokers retained through quit date –41% Female –6% Hispanic –70% White, 20% African American, 6% Asian American, 4% Other –Age M=45.2, SD=11.7, Range=20-74 –Cigarettes/day M=18.9, SD=6.9, Range=10-40 –Fagerstr öm Test of Nicotine Dependence M=5.3, SD=2.0, Range=1-9 –27% CO-confirmed abstinence 3 weeks post-quit

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Study Procedures Telephone screening Orientation session –CO testing –Questionnaires –ED training ED recording –Carry ED at all times, minute reports per day Office visits –Five weekly visits over 5 weeks Follow-up –Phone call 12 weeks post-quit –Possible 5-minute office visit at 12 weeks 13

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Baseline Measures Delay discounting –e.g., “Would you prefer $42 today or $100 in 1 week?” –Delayed rewards of $20-$2500 –Delays of 1 day-2 years –26 series of items, up to 50 questions per series –Used Johnson & Bickel, 2002 delay discounting algorithm to identify indifference points –1 choice up to $100 randomly selected to treat as real

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Baseline Measures Behavioral disinhibition –Continuous Performance Task-II (Conners & MHS Staff, 2000) –Press space bar for every letter but “X” –“X” appears on 10% of trials –6 blocks of 60 trials –Modified so trials with 1, 2, and 4 s inter-trial intervals interspersed randomly within blocks –$0.02 for every correct response –Feedback regarding errors and money earned between blocks

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior EMA Impulsiveness Measures Delay discounting –8 items per report –Rewards of $25-$100 at delays of 1-42 days –One report treated as real –Starting value of sooner reward (V p =V d /(1+k base D)) tailored to baseline discounting rate (k base =1/D(V d /V p -1)) –Next sooner reward based on previous responses (midpoint between min and max indifference points) –Final k based on estimated indifference point at 8 th question (k EMA =1/D(V d /V p -1))

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Sample Alarm Screen Alarm screen 17 Alert Friday, 7/13/ :45 pm-1:00 pm Private Appointment Snooze Go To Clear GO

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior EMA Discounting Instructions GO Remember... At least 1 of these choices will be REAL during the study! (Press Next to continue) Previous Next Welcome Please indicate which option, A or B, you prefer by tapping the letter. (Press Next to continue) Previous Next Daily k.01

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Sample EMA Discounting Items Would you prefer? 1A. $ today 1B. $ in 2 weeks Your choice: Previous Next AB Would you prefer? 2A. $ today 2B. $ in 2 weeks Your choice: Previous Next AB

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Additional Items 20 PAST 15 MINUTES Disagree Agree I have felt EXCITED Previous Next PAST 15 MINUTES… Please answer the next questions based on how you have FELT IN GENERAL in the PAST 15 MINUTES. (Press Next to continue) Previous Next

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Sample ED Items 21 PAST 15 MINUTES Disagree Agree I have felt EXCITED OK PAST 24 HOURS… Not At All Extremely How WILLING are you to WORK HARD AT QUITTING SMOKING? Previous Next I have felt EXCITED Missing Response Disagree Agree

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Final Sample Item and Ending a Report 22 JUST BEFORE PROMPT:  Home  Work/School  Vehicle  Restaurant/Bar  Public Place  Others’ Home  Outside  Other WHERE were you? Previous Next PAST 15 MINUTES… Have you been with SOMEONE WHO WAS SMOKING? Previous Next YesNo

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior More Sample Items 23 PAST 2 HOURS… How many CIGARETTES have you smoked IN THE PAST 2 HOURS? Previous Next PAST 2 HOURS… Previous Next Select one… How many CIGARETTES

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior EMA Measure of Behavioral Disinhibition 2-minute, 60-trial CPT-II DV=Commission error rate MiniCog software (Shephard, Kho, Chen, & Kosslyn, 2006; Cambridge, MA) –Custom programming of items through Adobe Dreamweaver (San Jose, CA) –Some limits (no multi-screen trials) –Reaction time temporal resolution ~10 ms –Requires extra log-in step –Randomization of items 24

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior MiniCog Next Login ID l______ Notes ____________ __________ __________ Sample Questions 25 MiniCog ______________________ Keyboard (0) abc123Int’l Done GO

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Instructions You will see a series of letters appear on the screen one at a time. Each time you see a letter, press the center GO key, except when the letter is an X. If the letter is an X, do nothing. Please press the GO key to continue The rate at which the letters appear may vary– so pay close attention. You will earn 2¢ for every correct response. Please press the GO key to continue. GO 2-minute, 60-trial CPT-II DV=Commission error rate GO

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior EMA CPT-II Task F X H GO

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Delay Discounting 7,204 records from 99 subjects

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Delay Discounting

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Delay Discounting *Jump

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Delay Discounting *Jump *Slope

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Delay Discounting *Jump Steeper in those high in cognitive instability *Slope Steeper in those high in cognitive instability

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Delay Discounting Unrelated to initial cessation failure or abstinence 3 weeks post-quit

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Behavioral Disinhibition 6,719 records from 91 subjects *Slope

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Behavioral Disinhibition Baseline error rate related to 3-week abstinence; EMA rates not predictive

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Discussion EMA measures significantly related to validated baseline behavioral measures Self-reported cognitive instability related to EMA discounting level and growth EMA measures did not predict abstinence above and beyond baseline measures

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Limitations Interim analysis with limited power Imperfect adherence to EMA assessment schedule Smoking not controlled for in models Skew in discounting and disinhibition distributions

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Future Directions Identify internal (e.g., craving) and contextual factors (e.g., exposure to smoking cues) associated with momentary fluctuations in impulsivity –Interim analyses suggest that positive affect, but not negative affect, predicts change in k Examine short-term relations between changes in impulsivity and subsequent smoking

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Collaborators Rutgers –Gretchen Chapman –Haruka Minami –Krysten Williams –Vivian Yeh –Haewon Yoon U. Pittsburgh –Saul Shiffman 39 U. Wisconsin –Timothy Baker –Michael Fiore –Doug Jorenby –Daniel Lawrence –Megan Piper –Stevens Smith U. Missouri-Columbia –Thomas Piasecki

Smoking Cessation Laboratory Tracking Impulsive Choice and Behavior Questions? Comments? 40